The DOI matches its Crossref record.
Lipopeptides from Bacillus and Paenibacillus spp.: A Gold Mine of Antibiotic Candidates
Abstract
The emergence of multidrug‐resistant bacteria has placed a strain on health care systems and highlighted the need for new classes of antibiotics. Bacterial lipopeptides are secondary metabolites, generally produced by nonribosomal peptide synthetases that often exhibit broad‐spectrum antimicrobial activity. Only two new structural types of antibiotics have entered the market in the last 40 years, linezolid and the bacterial lipopeptide daptomycin. A wide variety of bacteria produce lipopeptides, however Bacillus and Paenibacillus spp. in particular have yielded several potent antimicrobial lipopeptides. Many of the lipopeptides produced by these bacteria have been known for decades and represent a potential gold mine of antibiotic candidates. This list includes the polymyxins, octapeptins, polypeptins, iturins, surfactins, fengycins, fusaricidins, and tridecaptins, as well as some novel examples, including the kurstakins. These lipopeptides have a wide variety of activities, ranging from antibacterial and antifungal, to anticancer and antiviral. This review presents a reasonably comprehensive list of each class of lipopeptide and their known homologues. Emphasis has been placed on their antimicrobial activities, as well other potential applications for this interesting class of substances.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 161
- 10.1128/9781555817886 · DOI · Paper page
- 10.1126/science.293.5536.1786 · DOI · Paper page
- 10.1002/anie.200600350 · DOI · Paper page
- 10.1016/S0140-6736(11)60401-7 · DOI · Paper page
- 10.1371/journal.pmed.1001104 · DOI · Paper page
- Pirri G, 2009, Lipopeptides as anti‐infectives: A practical perspective, Cent Eur J Biol, 4, 258
- 10.1146/annurev.micro.58.030603.123615 · DOI · Paper page
- 10.7164/antibiotics.38.1610 · doi:10.7164/antibiotics.38.1610
- Stansly PG, 1947, Polymyxin: A new chemotherapeutic agent, Bull Johns Hopkins Hosp, 81, 43
- 10.1021/jm900999h · DOI · Paper page
- 10.1016/j.ab.2010.10.033 · doi:10.1016/j.ab.2010.10.033
- 10.1002/cbic.201300496 · DOI
- 10.1186/cc3995 · DOI · Paper page
- 10.1128/AAC.02587-12 · DOI
- 10.1111/j.1749-6632.1949.tb27318.x · doi:10.1111/j.1749-6632.1949.tb27318.x
- 10.1128/AAC.00119-11 · doi:10.1128/aac.00119-11
- 10.1016/S0021-9673(00)92299-4 · doi:10.1016/s0021-9673(00)92299-4
- 10.1007/BF01901128 · doi:10.1007/bf01901128
- 10.7164/antibiotics.54.595 · doi:10.7164/antibiotics.54.595
- 10.1074/jbc.M212364200 · doi:10.1074/jbc.m212364200
- 10.7164/antibiotics.26.444 · doi:10.7164/antibiotics.26.444
- 10.7164/antibiotics.26.449 · doi:10.7164/antibiotics.26.449
- 10.7164/antibiotics.26.457 · doi:10.7164/antibiotics.26.457
- 10.7164/antibiotics.28.379 · DOI
- 10.1111/j.1749-6632.1974.tb43286.x · DOI
- 10.1016/S0021-9673(01)97597-1 · doi:10.1016/s0021-9673(01)97597-1
- 10.7164/antibiotics.29.1339 · doi:10.7164/antibiotics.29.1339
- 10.7164/antibiotics.29.516 · doi:10.7164/antibiotics.29.516
- 10.7164/antibiotics.29.521 · doi:10.7164/antibiotics.29.521
- 10.7164/antibiotics.29.1241 · doi:10.7164/antibiotics.29.1241
- 10.7164/antibiotics.36.634 · doi:10.7164/antibiotics.36.634
- 10.1128/AAC.12.6.665 · doi:10.1128/aac.12.6.665
- 10.7164/antibiotics.32.511 · doi:10.7164/antibiotics.32.511
- 10.1128/AAC.05580-11 · DOI
- 10.7164/antibiotics.33.186 · doi:10.7164/antibiotics.33.186
- Howell SF, 1950, Polypeptin, an antibiotic from a member of the Bacillus circulans group. II. Purification, crystallization, and properties of polypeptin, J Biol Chem, 186, 863, 10.1016/S0021-9258(18)56279-7 · DOI
- Hausmann W, 1952, Polypeptin; purification, molecular weight determination, and amino acid composition, J Biol Chem, 198, 405, 10.1016/S0021-9258(18)55594-0 · doi:10.1016/s0021-9258(18)55594-0
- 10.1021/jm00232a012 · DOI
- 10.7164/antibiotics.32.121 · doi:10.7164/antibiotics.32.121
- 10.7164/antibiotics.32.115 · doi:10.7164/antibiotics.32.115
- 10.1111/j.1574-6968.2010.02040.x · doi:10.1111/j.1574-6968.2010.02040.x
- 10.1186/1471-2180-12-197 · doi:10.1186/1471-2180-12-197
- 10.1007/s12275-011-1153-7 · doi:10.1007/s12275-011-1153-7
- 10.7164/antibiotics.37.1257 · doi:10.7164/antibiotics.37.1257
- 10.1111/j.1574-6968.1995.tb07887.x · DOI
- 10.1128/AEM.07782-11 · DOI
- 10.1128/JB.01506-12 · doi:10.1128/jb.01506-12
- 10.1016/S0378-1097(03)00329-X · DOI
- 10.1128/AEM.70.1.631-634.2004 · DOI
- 10.1016/S0038-0717(02)00027-5 · DOI · Paper page
- 10.1021/bi00612a018 · DOI · Paper page
- 10.1016/0040-4020(78)80138-0 · DOI
- 10.7164/antibiotics.36.1451 · DOI
- 10.1248/cpb.52.1029 · DOI
- 10.1016/j.febslet.2010.06.005 · DOI
- 10.7164/antibiotics.39.636 · DOI
- 10.1038/ja.2012.19 · DOI
- 10.1111/j.1432-1033.1985.tb09307.x · DOI
- 10.7164/antibiotics.37.1600 · DOI
- 10.7164/antibiotics.48.1095 · DOI
- 10.7164/antibiotics.48.1240 · DOI
- 10.1016/0014-5793(78)80292-0 · doi:10.1016/0014-5793(78)80292-0
- 10.1016/0005-2736(85)90367-0 · DOI
- 10.1016/0005-2736(89)90042-4 · DOI
- 10.1007/BF00436368 · DOI
- 10.7164/antibiotics.31.284 · DOI
- 10.1016/S0038-0717(02)00027-5 · DOI · Paper page
- 10.1111/j.1745-7270.2006.00157.x · DOI
- Pyoung K, 2010, Production of biosurfactant lipopeptides iturin A, fengycin, and surfactin a from Bacillus subtilis CMB32 for control of Colletotrichum gloeosporioides, J Microbiol Biotechn, 20, 138, 10.4014/jmb.0905.05007 · DOI · Paper page
- Tenoux I, 1993, Studies on bacillomycin D biosynthesis by Bacillus subtilis, Microbios, 74, 29
- 10.1046/j.1365-2672.2001.01290.x · DOI · Paper page
- 10.7164/antibiotics.35.306 · DOI
- 10.1128/AEM.71.8.4577-4584.2005 · DOI · Paper page
- 10.1016/j.jcis.2012.07.091 · DOI
- 10.1016/j.bbamem.2005.05.003 · DOI · Paper page
- 10.2174/138620703106298716 · DOI · Paper page
- 10.2478/s11536-008-0002-5 · DOI · Paper page
- Shaligram NS, 2010, Surfactin—a review on biosynthesis, fermentation, purification and applications, Food Technol Biotechn, 48, 119
- Kakinuma A, 1969, Determination of fatty acid in surfactin and elucidation of the total structure of surfactin, Agr Biol Chem Tokyo, 33, 973, 10.1080/00021369.1969.10859409 · DOI
- 10.1111/j.1432-1033.1994.tb19998.x · DOI
- 10.1007/BF00122922 · DOI
- 10.1111/j.1432-1033.1991.tb16349.x · DOI
- 10.1016/0006-291X(91)90637-M · DOI
- 10.1002/(SICI)1099-1387(199703)3:2<145::AID-PSC96>3.0.CO;2-Y · doi:10.1002/(sici)1099-1387(199703)3:2<145::aid-psc96>3.0.co;2-y
- 10.1006/jcis.1998.5558 · DOI · Paper page
- 10.7164/antibiotics.43.267 · DOI · Paper page
- 10.1385/ABAB:90:3:199 · DOI
- 10.1016/S0005-2736(99)00039-5 · DOI
- 10.1007/s00249-006-0091-5 · DOI · Paper page
- 10.1016/0021-9797(92)90319-H · doi:10.1016/0021-9797(92)90319-h
- 10.1111/j.1470-8744.1992.tb00218.x · DOI
- 10.7164/antibiotics.36.674 · DOI
- 10.7164/antibiotics.52.613 · DOI · Paper page
- 10.1006/biol.1997.0099 · DOI · Paper page
- Vollenbroich D, 1997, Antimycoplasma properties and application in cell culture of surfactin, a lipopeptide antibiotic from Bacillus subtilis, Appl Environ Microb, 63, 44, 10.1128/aem.63.1.44-49.1997 · DOI · Paper page
- 10.1128/AAC.01030-06 · doi:10.1128/aac.01030-06
- 10.1248/cpb.22.938 · DOI
- 10.1016/j.febslet.2007.01.059 · DOI · Paper page
- 10.1007/s10529-005-2515-1 · doi:10.1007/s10529-005-2515-1
- 10.1016/j.ejphar.2006.10.031 · DOI
- Dehghan‐Noudeh G, 2005, Isolation, characterization, and investigation of surface and hemolytic activities of a lipopeptide biosurfactant produced by Bacillus subtilis ATCC 6633, J Microbiol, 43, 272
- 10.1016/S0006-3495(01)75808-0 · DOI · Paper page
- 10.1093/protein/15.11.913 · DOI
- 10.1016/j.bbagen.2005.06.015 · DOI
- 10.1016/S0040-4039(00)77249-2 · DOI
- 10.7164/antibiotics.52.363 · DOI
- Yakimov MM, 1999, Structural characterization of lichenysin a components by fast atom bombardment tandem mass spectrometry, BBA‐Mol Cell Biol L, 1438, 273
- 10.7164/antibiotics.39.888 · DOI · Paper page
- 10.1016/j.mimet.2009.09.013 · doi:10.1016/j.mimet.2009.09.013
- 10.1007/s13361-012-0437-4 · DOI
- 10.1021/np300574v · doi:10.1021/np300574v
- Sang‐Cheol L, 2010, Isolation, purification, and characterization of novel fengycin S from Bacillus amyloliquefaciens Lsc04 degrading‐crude oil, Biotechnol Bioeng, 15, 246
- 10.7164/antibiotics.39.755 · DOI
- 10.1016/j.bmc.2012.04.040 · doi:10.1016/j.bmc.2012.04.040
- 10.1016/j.tim.2007.12.009 · DOI · Paper page
- 10.1128/JB.186.4.1084-1096.2004 · DOI · Paper page
- 10.7164/antibiotics.39.888 · DOI · Paper page
- 10.1007/s00438-004-1056-y · DOI · Paper page
- 10.1139/W07-049 · DOI · Paper page
- 10.1529/biophysj.107.114090 · DOI · Paper page
- 10.1016/j.jcis.2004.09.036 · DOI · Paper page
- 10.1016/j.bbamem.2011.04.008 · doi:10.1016/j.bbamem.2011.04.008
- 10.7164/antibiotics.50.529 · doi:10.7164/antibiotics.50.529
- 10.7164/antibiotics.56.716 · doi:10.7164/antibiotics.56.716
- 10.7164/antibiotics.39.737 · DOI
- Yin H, 2013, Fengycin inhibits the growth of the human lung cancer cell line 95D through reactive oxygen species production and mitochondria‐dependent apoptosis, Anti‐Cancer Drugs, 24, 587, 10.1097/CAD.0b013e3283611395 · DOI
- 10.7164/antibiotics.49.129 · DOI · Paper page
- 10.7164/antibiotics.50.220 · DOI
- 10.7164/antibiotics.40.1506 · doi:10.7164/antibiotics.40.1506
- 10.1139/w02-002 · doi:10.1139/w02-002
- 10.1016/j.mimet.2011.02.013 · DOI
- 10.1002/cmdc.201200016 · DOI
- 10.7164/antibiotics.25.243 · DOI
- 10.1007/s10658-009-9496-1 · doi:10.1007/s10658-009-9496-1
- 10.1007/s12600-012-0263-z · doi:10.1007/s12600-012-0263-z
- 10.1002/hlca.201000094 · doi:10.1002/hlca.201000094
- 10.1021/np000169q · DOI · Paper page
- 10.1007/s00253-012-4181-2 · DOI
- 10.7164/antibiotics.25.304 · doi:10.7164/antibiotics.25.304
- 10.7164/antibiotics.25.147 · doi:10.7164/antibiotics.25.147
- 10.7164/antibiotics.25.309 · DOI
- 10.7164/antibiotics.28.60 · doi:10.7164/antibiotics.28.60
- 10.7164/antibiotics.28.56 · doi:10.7164/antibiotics.28.56
- 10.7164/antibiotics.28.764 · doi:10.7164/antibiotics.28.764
- 10.7164/antibiotics.29.1281 · doi:10.7164/antibiotics.29.1281
- 10.7164/antibiotics.29.1275 · doi:10.7164/antibiotics.29.1275
- 10.7164/antibiotics.29.1268 · doi:10.7164/antibiotics.29.1268
- 10.7164/antibiotics.32.313 · doi:10.7164/antibiotics.32.313
- 10.7164/antibiotics.31.652 · doi:10.7164/antibiotics.31.652
- 10.7164/antibiotics.32.305 · doi:10.7164/antibiotics.32.305
- 10.1021/ja3089229 · DOI
- 10.1002/cbic.201300595 · doi:10.1002/cbic.201300595
- 10.1021/jm401779d · doi:10.1021/jm401779d
- 10.1016/j.ccc.2007.12.003 · doi:10.1016/j.ccc.2007.12.003
- 10.1093/jac/dkm357 · DOI · Paper page
- 10.3389/fmicb.2013.00332 · DOI
- 10.1016/j.micres.2012.11.004 · DOI
- 10.1016/S0923-2508(97)87647-4 · DOI
- 10.1007/s11274-008-9752-0 · doi:10.1007/s11274-008-9752-0
- 10.1002/cbic.201402024 · DOI
- Clinical and Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard‐ninth edition and performance standards for antimicrobial susceptibility testing2013;33(1):142–143.
Cited by
Current knowledge and perspectives of Paenibacillus: a review
Grady, E. N., MacDonald, J., Liu, L., Richman, A., & Yuan, Z.-C. (2016) · Microbial Cell Factories · doi:10.1186/s12934-016-0603-7 · Cited by 1,003
Biological control of plant pathogens by Bacillus species
Fira, D., Dimkić, I., Berić, T., Lozo, J., & Stanković, S. (2018) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2018.07.044 · Cited by 917
Development and Challenges of Antimicrobial Peptides for Therapeutic Applications
Chen, C. H., & Lu, T. K. (2020) · Antibiotics · doi:10.3390/antibiotics9010024 · Cited by 598
Kumariya, R., Garsa, A. K., Rajput, Y. S., Sood, S. K., Akhtar, N., & Patel, S. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.01.002 · Cited by 455
Chemically modified and conjugated antimicrobial peptides against superbugs
Li, W., Separovic, F., O'Brien-Simpson, N. M., & Wade, J. D. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01026j · Cited by 439
Metadata
- Authors
- Cochrane, S. A., & Vederas, J. C.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2014-05-28
- Volume
- 36
- Issue
- 1
- Pages
- 4-31
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W2137992445
- Cited by
- 474
- References
- 0
- FWCI
- 17.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Funders
- Natural Sciences and Engineering Research Council of Canada
- Griffith Laboratories Canada; Canada Research Chair in Bioorganic and Medicinal Chemistry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lipopeptides from Bacillus and Paenibacillus spp.: A Gold Mine of Antibiotic Candidates. https://app.cochat.ai/papers/10.1002/med.21321
- The paper
- Cochrane, S. A., & Vederas, J. C. (2016). Lipopeptides from Bacillus and Paenibacillus spp.: A Gold Mine of Antibiotic Candidates. Medicinal Research Reviews. https://doi.org/10.1002/med.21321
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.